Insulin aspart, recombinant Subcutaneous and Levorphanol Tartrate
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Levorphanol Tartrate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: levorphanol
Brand name: Levo-Dromoran
Synonyms: Levorphanol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Levothroid
- Insulin aspart, recombinant Subcutaneous-Levothyroxine
- Insulin aspart, recombinant Subcutaneous-Levothyroxine and Liothyronine Tablets
- Insulin aspart, recombinant Subcutaneous-Levothyroxine Capsules
- Insulin aspart, recombinant Subcutaneous-Levothyroxine Injection
- Insulin aspart, recombinant Subcutaneous-Levothyroxine Injection Solution
- Levorphanol Tartrate-Insulin degludec
- Levorphanol Tartrate-Insulin Degludec (U-100) Prefilled Pens
- Levorphanol Tartrate-Insulin Degludec (U-100) Vials
- Levorphanol Tartrate-Insulin Degludec (U-200) Prefilled Pens
- Levorphanol Tartrate-Insulin degludec and liraglutide
- Levorphanol Tartrate-Insulin degludec and liraglutide Subcutaneous